SEC 13F Intelligence

Octagon Capital Advisors LP / KYMR

Octagon Capital Advisors LP’s Kymera Therapeutics Inc Position

Does Octagon Capital Advisors LP own Kymera Therapeutics Inc (KYMR)? Yes — 425.0K shares worth $35M (+3.92% of its 13F portfolio) as of Q1 2026, down from 535.0K shares the prior filed quarter.

Position Value
$35M
Q1 2026
Shares
425.0K
% of Portfolio
+3.92%
Quarters Held
5
currently held

Position History KYMR

Reported value by quarter
Q2 ’21: $5MQ2 ’21Q2 ’25: $12MQ2 ’25Q3 ’25: $20MQ3 ’25Q4 ’25: $42MQ4 ’25Q1 ’26: $35MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026425.0K$35M+3.92%
Q4 2025535.0K$42M+5.05%
Q3 2025360.0K$20M+3.09%
Q2 2025266.0K$12M+2.55%
Q2 2021100.0K$5M+1.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Octagon Capital Advisors LP’s full portfolio or all institutional holders of KYMR.